Cara Therapeutics reported $9.31M in Trade Creditors for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US $ 6M 0M
Aerie Pharmaceuticals AERI:US $ 6M 3M
Antares Pharma ATRS:US $ 18M 0M
Biodelivery Sciences International BDSI:US $ 13.29M 4.41M
Chugai Pharma 4519:JP Y 87037M 23861M
Depomed DEPO:US $ 22.98M 5.55M
Endo International Ordinary Shares ENDP:US $ 104.62M 8.43M
Halozyme Therapeutics HALO:US $ 4.07M 4.25M
Horizon Pharma HZNP:US $ 38.98M 67.04M
JAZZ PHA JAZZ:US $ 67.06M 17.02M
Johnson & Johnson JNJ:US $ 7044M 279M
Pacira Pharmaceuticals PCRX:US $ 9.16M 6.69M
Pfizer PFE:US $ 3872M 100M
Redhill Biopharma RDHL:US $ 6.57M 1.26M
Revance Therapeutics RVNC:US $ 6.6M 2.11M
Teva Pharmaceutical Industries TEVA:US $ 1716M 110M
Vanda Pharmaceuticals VNDA:US $ 5.42M 0.51M